← Back to patent-cliff list
乙醇达芦那韦
Tier C — Watch / tradeDarunavir Ethanolate
蒂博泰克
Originator
2006
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：HIV-1 protease
Brand：Prezista、darunavir
Indications (approved)：HIV感染
Regional status
US
批准上市
2006-06-23
EU
批准上市
2007-02-11
China
批准上市
2008-09-02
Japan
批准上市
2007-11-22
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Darunavir Ethanolate?
Approved indications include: HIV感染.
When does the Darunavir Ethanolate patent expire?
No public expiry year is available for Darunavir Ethanolate yet; this page updates once verified.
How do I get a quote for Darunavir Ethanolate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25